Talk:Immunoglobulin therapy

Immunoglobulin therapy
Clinical data
Trade names	Flebogamma, Gammagard, Hizentra, others
Other names	normal human immunoglobulin (HNIG), human normal immunoglobulin (HNIG)
AHFS/Drugs.com	Monograph
License data	US DailyMed: Immune_globulin;
Pregnancy; category	AU: Exempt; ;
Routes of; administration	Intravenous, intramuscular, subcutaneous
ATC code	J06BA (WHO) ;
Legal status
Legal status	AU: S4 (Prescription only) ; CA: ℞-only ; US: ℞-only ; EU: Rx-only ; In general: ℞ (Prescription only);
Identifiers
CAS Number	9007-83-4 ;
ChemSpider	none;
UNII	66Y330CJHS;

↑ ^1.0 ^1.1 "Xembify APMDS". Therapeutic Goods Administration (TGA). 15 July 2022. Archived from the original on 14 July 2022. Retrieved 17 July 2022.
↑ "Regulatory Decision Summary - Xembify". Health Canada. 23 October 2014. Archived from the original on 7 June 2022. Retrieved 7 June 2022.
↑ "Summary Basis of Decision - HyQvia". Health Canada. 23 October 2014. Retrieved 6 August 2022.

Navigation menu